000 | 01167 a2200349 4500 | ||
---|---|---|---|
005 | 20250518060215.0 | ||
264 | 0 | _c20200210 | |
008 | 202002s 0 0 eng d | ||
022 | _a1875-8630 | ||
024 | 7 |
_a10.1155/2019/4096847 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHodel, Markus | |
245 | 0 | 0 |
_asFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective. _h[electronic resource] |
260 |
_bDisease markers _c2019 |
||
300 |
_a4096847 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 | _aCosts and Cost Analysis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMembrane Proteins _xblood |
650 | 0 | 4 |
_aPre-Eclampsia _xblood |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 | _aSwitzerland |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-1 _xblood |
700 | 1 | _aBlank, Patricia R | |
700 | 1 | _aMarty, Petra | |
700 | 1 | _aLapaire, Olav | |
773 | 0 |
_tDisease markers _gvol. 2019 _gp. 4096847 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1155/2019/4096847 _zAvailable from publisher's website |
999 |
_c30076845 _d30076845 |